Dinesh C. Paliwal's most recent trade in Raytheon Technologies Corporation was a trade of 4,096 Phantom Stock Unit done . Disclosure was reported to the exchange on May 2, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| RTX | Dinesh C. Paliwal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 4,096 | 19,198 | - | - | Phantom Stock Unit | |
| RTX | Dinesh C. Paliwal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2022 | 3,915 | 14,747 | - | - | Phantom Stock Unit | |
| RTX | Dinesh C. Paliwal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2021 | 4,814 | 10,585 | - | - | Phantom Stock Unit | |
| Bristol-Myers Squibb | Dinesh C. Paliwal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 613 | 40,501 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb | Dinesh C. Paliwal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 3,054 | 39,887 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb | Dinesh C. Paliwal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2020 | 624 | 39,801 | - | - | Deferred Share Units | |
| RTX | Dinesh C. Paliwal | Director | Purchase of securities on an exchange or from another person at price $ 52.41 per share. | 29 Oct 2020 | 9,532 | 19,946 (0%) | 0% | 52.4 | 499,546 | Common Stock |
| Bristol-Myers Squibb | Dinesh C. Paliwal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2020 | 642 | 35,650 | - | - | Deferred Share Units |